| Jessica Thigpen Legge, PHARMD | |
|
7 S Morgan Ave, Andrews, SC 29510-2694 | |
| (843) 264-5454 | |
| (843) 264-8362 |
| Full Name | Jessica Thigpen Legge |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7 S Morgan Ave, Andrews, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275126278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10593 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Thigpen Legge, PHARMD 7 S Morgan Ave, Andrews, SC 29510-2694 Ph: (843) 264-5454 | Jessica Thigpen Legge, PHARMD 7 S Morgan Ave, Andrews, SC 29510-2694 Ph: (843) 264-5454 |
News Archive
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
Genetic testing for inherited blood-clotting abnormalities is not routinely recommended for patients with venous thromboembolism (VTE) of unknown cause, according to a new expert panel statement in a recent issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG).
Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.
PATH and Standard Diagnostics/Alere announced today the commercial availability of two rapid diagnostic tools for onchocerciasis and lymphatic filariasis. Designed for use in disease surveillance, the antibody-based tests are part of a suite of diagnostic innovations intended to support the elimination of neglected tropical diseases (NTDs), a group of illnesses that affect more than a billion people worldwide.
A new animal study, published in the Journal of Clinical Biochemistry and Nutrition, suggests regular walnut consumption may be a promising intervention for reducing negative outcomes associated with Helicobacter pylori (H. pylori) infection, a widespread bacterial infection that affects more than half of the world's population.
› Verified 9 days ago
Mr. Thomas Ostavus Morris, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 W Oakland St, Andrews, SC 29510 Phone: 843-264-3357 Fax: 843-264-8188 | |
Dr. Tracey Haddock, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 W Ashland St, Andrews, SC 29510 Phone: 843-264-3291 Fax: 843-264-5425 | |
Bryan Dry, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 E Main St, Andrews, SC 29510 Phone: 843-264-6656 | |
Terri Angelic1 Howard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 E Main St, Andrews, SC 29510 Phone: 843-264-6656 Fax: 843-264-6684 | |
Lisa Morris, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 S Morgan Ave, Andrews, SC 29510 Phone: 843-264-5454 | |
Mr. Richard Gregory Simpson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 415 E Brooks Rd, Andrews, SC 29510 Phone: 843-264-3045 Fax: 843-264-8098 |